On May 4, 2026, Mergers & Acquisitions named the 12 winners of its Middle-Market Deals of the Year award, along with the 22 deals receiving honorable mentions. Two deals led by Wilson Sonsini were named among the honorable mentions this year: Boston Scientific's merger with Bolt Medical and Transcarent's acquisition of Accolade.

Transcarent's acquisition of Accolade, with a total equity value of approximately $861 million, represents a significant advancement in AI application within the healthcare sector. Wilson Sonsini advised Transcarent on the transaction.

Boston Scientific’s acquisition of Bolt Medical, Inc., is expected to enhance Boston Scientific’s cardiovascular portfolio and advance the company’s strategy to address coronary and peripheral disease. Wilson Sonsini advised Bolt Medical on the transaction.

For more information, please see our client highlights on the Transcarent and Bolt Medical transactions.

To view the complete list of winners and honorable mentions, please visit the Mergers & Acquisitions site (subscription required).